<DOC>
	<DOCNO>NCT01758887</DOCNO>
	<brief_summary>- Would difference dopamine synthesis remit clinical high risk subject psychosis healthy control ? - What would happen dopamine synthesis antipsychotic discontinuation clinical high risk subject psychosis ? - What dopamine synthesis recur clinical high risk subject psychosis discontinuation ?</brief_summary>
	<brief_title>Antipsychotic Discontinuation High-risk Subjects</brief_title>
	<detailed_description>After antipsychotic medication discontinuation , go assess change biological marker</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Diagnosed clinical High Risk Treated antipsychotic drug PSP15 ( SIPS criterion ) &lt; 3 ( severity index ) 6 month Had experience symptomatic relapse 6 month Significant abnormality laboratory test History head trauma</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>